Weight-loss drugs could stop hormone replacement therapy from working and increase the associated risks, guidance has warned.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

After working with a string of top-flight directors like Francis Ford Coppola and Quentin Tarantino , she suffered an ...

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

Demand for cosmetic procedures to fix Sydneysiders’ saggy skin and lost facial fat associated with weight-loss drugs has ...

In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...

Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...

Spread This News By Staff Reporter  THE Medicines Control Authority of Zimbabwe (MCAZ) and the Health Professions Authority ...

Rumour has it Karan Johar secretly flew to South Korea multiple times to get… his face insured. Yup, inspired by a close friend, and apparently it’s a trend there. Insiders say he’s been way more ...

The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.

The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...